Free Trial
NASDAQ:RFAI

RF Acquisition Corp II (RFAI) Stock Price, News & Analysis

RF Acquisition Corp II logo
$10.49 +0.02 (+0.18%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About RF Acquisition Corp II Stock (NASDAQ:RFAI)

Key Stats

Today's Range
$10.48
$10.49
50-Day Range
$10.37
$10.55
52-Week Range
$10.00
$10.50
Volume
5,900 shs
Average Volume
55,905 shs
Market Capitalization
$157.33 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

RF Acquisition Corp. II operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 5, 2024, and is headquartered in Singapore.

Receive RFAI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RF Acquisition Corp II and its competitors with MarketBeat's FREE daily newsletter.

RFAI Stock News Headlines

RF Acquisition Corp II Audit Committee Resignation
See More Headlines

RFAI Stock Analysis - Frequently Asked Questions

RF Acquisition Corp II's stock was trading at $10.22 on January 1st, 2025. Since then, RFAI stock has increased by 2.5% and is now trading at $10.48.
View the best growth stocks for 2025 here
.

Top institutional investors of RF Acquisition Corp II include AQR Arbitrage LLC (5.22%), Schechter Investment Advisors LLC (4.57%), Wolverine Asset Management LLC (4.20%) and Wealthspring Capital LLC (0.58%).

Shares of RFAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that RF Acquisition Corp II investors own include Arch Capital Group (ACGL), Adobe (ADBE), Analog Devices (ADI), Alnylam Pharmaceuticals (ALNY), Amgen (AMGN), AstraZeneca (AZN) and Baidu (BIDU).

Company Calendar

Today
5/21/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
Holding & other investment offices
Sub-Industry
Trading
Current Symbol
NASDAQ:RFAI
Previous Symbol
NASDAQ:RFAI
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$157.33 million
Optionable
N/A
Beta
N/A
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NASDAQ:RFAI) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners